216 related articles for article (PubMed ID: 2025558)
1. Relative efficacy of 335 and 365 nm radiation in photochemotherapy of psoriasis.
Brücke J; Tanew A; Ortel B; Hönigsmann H
Br J Dermatol; 1991 Apr; 124(4):372-4. PubMed ID: 2025558
[TBL] [Abstract][Full Text] [Related]
2. PUVA erythemal sensitivity depends on plasma psoralen concentration and UVA sensitivity.
Sakuntabhai A; Farr PM; Diffey BL
Br J Dermatol; 1993 May; 128(5):561-5. PubMed ID: 8504050
[TBL] [Abstract][Full Text] [Related]
3. The action spectrum between 320 and 400 nm for clearance of psoriasis by psoralen photochemotherapy.
Farr PM; Diffey BL; Higgins EM; Matthews JN
Br J Dermatol; 1991 May; 124(5):443-8. PubMed ID: 2039720
[TBL] [Abstract][Full Text] [Related]
4. Erythemal and therapeutic response of psoriasis to PUVA using high-dose UVA.
Speight EL; Farr PM
Br J Dermatol; 1994 Nov; 131(5):667-72. PubMed ID: 7999598
[TBL] [Abstract][Full Text] [Related]
5. Narrow band UVB (311 nm) phototherapy and PUVA photochemotherapy: a combination.
Calzavara-Pinton P
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):687-90. PubMed ID: 9591811
[TBL] [Abstract][Full Text] [Related]
6. A reappraisal of the use of 5-methoxypsoralen in the therapy of psoriasis.
Calzavara-Pinton P; Ortel B; Carlino A; Honigsmann H; De Panfilis G
Exp Dermatol; 1992 Jul; 1(1):46-51. PubMed ID: 1344660
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema.
Cox NH; Farr PM; Diffey BL
Arch Dermatol; 1989 Dec; 125(12):1653-7. PubMed ID: 2589859
[TBL] [Abstract][Full Text] [Related]
8. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA.
Legat FJ; Hofer A; Quehenberger F; Kahofer P; Kerl H; Wolf P
J Am Acad Dermatol; 2004 Nov; 51(5):746-54. PubMed ID: 15523353
[TBL] [Abstract][Full Text] [Related]
9. 8-MOP PUVA for psoriasis: a comparison of a minimal phototoxic dose-based regimen with a skin-type approach.
Collins P; Wainwright NJ; Amorim I; Lakshmipathi T; Ferguson J
Br J Dermatol; 1996 Aug; 135(2):248-54. PubMed ID: 8881668
[TBL] [Abstract][Full Text] [Related]
10. Erythema action spectrum of topical 8-methoxypsoralen-sensitized skin re-evaluated: implications for routine clinical practice.
Al-Ismail D; Edwards C; Anstey AV
Br J Dermatol; 2016 Jan; 174(1):131-5. PubMed ID: 26383592
[TBL] [Abstract][Full Text] [Related]
11. Large increments in psoralen-ultraviolet A (PUVA) therapy are unsuitable for fair-skinned individuals with psoriasis.
Kirby B; Buckley DA; Rogers S
Br J Dermatol; 1999 Apr; 140(4):661-6. PubMed ID: 10233317
[TBL] [Abstract][Full Text] [Related]
12. Comparison of narrow-band (311 nm) UVB and broad-band UVA after oral or bath-water 8-methoxypsoralen in the treatment of psoriasis.
Ortel B; Perl S; Kinaciyan T; Calzavara-Pinton PG; Hönigsmann H
J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):736-40. PubMed ID: 8227546
[TBL] [Abstract][Full Text] [Related]
13. Half-side comparison of erythemogenic versus suberythemogenic UVA doses in oral photochemotherapy of psoriasis.
Tanew A; Ortel B; Hönigsmann H
J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):408-13. PubMed ID: 10459114
[TBL] [Abstract][Full Text] [Related]
14. PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen.
Lowe NJ; Weingarten D; Bourget T; Moy LS
J Am Acad Dermatol; 1986 May; 14(5 Pt 1):754-60. PubMed ID: 3711379
[TBL] [Abstract][Full Text] [Related]
15. The relationship between plasma psoralen concentration and psoralen-UVA erythema.
Mclelland J; Fisher C; Farr PM; Diffey BL; Cox NH
Br J Dermatol; 1991 Jun; 124(6):585-90. PubMed ID: 2064944
[TBL] [Abstract][Full Text] [Related]
16. Bath-5-methoxypsoralen-UVA therapy for psoriasis.
Calzavara-Pinton PG; Zane C; Carlino A; De Panfilis G
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060
[TBL] [Abstract][Full Text] [Related]
17. Response of psoriasis to twice weekly PUVA.
Sakuntabhai A; Sharpe GR; Farr PM
Br J Dermatol; 1993 Feb; 128(2):166-71. PubMed ID: 8457450
[TBL] [Abstract][Full Text] [Related]
18. [Principles of photochemotherapy and of the determination of the initial dosage of long-wave ultraviolet rays in the photochemotherapy (PUVA) method of treatment].
Vladimirov VV
Vestn Dermatol Venerol; 1981 Jan; (1):19-24. PubMed ID: 7210865
[No Abstract] [Full Text] [Related]
19. Glutathione S-transferase genotype is associated with sensitivity to psoralen-ultraviolet A photochemotherapy.
Ibbotson SH; Dawe RS; Dinkova-Kostova AT; Weidlich S; Farr PM; Ferguson J; Wolf CR; Smith G
Br J Dermatol; 2012 Feb; 166(2):380-8. PubMed ID: 21967523
[TBL] [Abstract][Full Text] [Related]
20. Antipsoriatic, erythematogenic, and Langerhans cell marker depleting effect of bath-psoralens plus ultraviolet A treatment. Comparison of 8-methoxypsoralen and trimethylpsoralen photosensitization.
Koulu LM; Jansén CT
J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1053-9. PubMed ID: 2968374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
